Home/SAB Biotherapeutics/Samuel J. Reich

SJ

Samuel J. Reich

Chief Executive Officer

SAB Biotherapeutics

Therapeutic Areas

Autoimmune Diseases Infectious Diseases

SAB Biotherapeutics Pipeline

Drug	Indication	Phase
SAB-142	Type 1 Diabetes	Phase 2
SAB-185	COVID-19 (SARS-CoV-2)	Phase 2/3
SAB-176	Influenza	Phase 1

Leadership Team at SAB Biotherapeutics

Eddie J. Sullivan

Co-Founder, President & Chief Operating Officer

Alexander G. Krouse

Chief Financial Officer

David P. Pearson

Chief Business Officer

Joseph M. Casper

Chief Scientific Officer

Theodore R. Heise

Chief Medical Officer

View full SAB Biotherapeutics profile